Long-Term Follow-Up of Brachytherapy for Treatment of Allograft In-Stent Restenosis

Catheterization and Cardiovascular Interventions

Volumn 61, Issue 2, 2004, Pages 217-221

  Zoghbi, Gilbert J ^a   Misra, Vijay K ^a,b   Chapman, Gregory D ^a   Hillegass, William B ^a   Brott, Brigitta C ^a   Aqel, Raed A ^a   Bourge, Robert C ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Allograft vasculopathy; Brachytherapy; In stent restenosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATORVASTATIN; CLONIDINE; CYCLOSPORIN; DILTIAZEM; ENALAPRIL; FOLIC ACID; GEMFIBROZIL; HYDRALAZINE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PRAVASTATIN; PREDNISONE; STRONTIUM 90;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHERECTOMY; BETA RADIATION; BRACHYTHERAPY; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIOMYOPATHY; CASE REPORT; CORONARY STENT; EXCIMER LASER; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IN STENT RESTENOSIS; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; STENT; TREATMENT OUTCOME; VASCULAR DISEASE;

BRACHYTHERAPY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; STENTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0742270473     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10689     Document Type: Article

References (18)

1. Wong PM, Piamsomboon C, Mathur A, Chastain HD II, Singh DJ, Liu MW, Parks JM, Iyer S, Dean LS, Baxley WA, Bourge RC, Roubin GS. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. Am J Cardiol 1998;82:239-241.
2. Redonnet M, Tron C, Koning R, Bouchart F, Cribier A, Soyer R, Bessou JP. Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation. Transplant Proc 2000;32:463-465.
3. Heublein B, Pethig K, Maass C, Wahlers T, Haverich A. Coronary artery stenting in cardiac allograft vascular disease. Am Heart J 1997;134:930-938.
4. Jain SP, Ramee SR, White CJ, Mehra MR, Ventura HO, Zhang S, Jenkins JS, Collins TJ. Coronary stenting in cardiac allograft vasculopathy. J Am Coll Cardiol 1998;32:1636-1640.
5. Grise MA, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Cloutier DA, Leon MB, Tripuraneni P, Teirstein PS. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2002;105:2737-2740.
6. Thew ST, Snell RJ, Klein LW. First use of intracoronary beta-radiation to prevent recurrent in-stent restenosis in a transplanted heart. Catheter Cardiovasc Interv 2002;55:373-375.
7. Urban P, Serruys P, Baumgart D, Colombo A, Silber S, Eeckhout E, Gershlick A, Wegscheider K, Verhees L, Bonan R. A multicentre European registry of intraluminal coronary beta brachytherapy. Eur Heart J 2003;24:604-612.
8. Klauss V, Stempfle H, Theisen K, Kantlehner R, Poellinger B, Reichart B, Schiele TM. Vascular brachytherapy for treatment of cardiac allograft vasculopathy. J Heart Lung Transplant 2001;20:792-794.
9. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: seventeenth official report, 2000. J Heart Lung Transplant 2000;19:909-931.
10. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992;11:S38-S44.
11. Johnson DE, Alderman EL, Schroeder JS, Gao SZ, Hunt S, DeCampli WM, Stinson E, Billingham M. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol 1991;17:449-457.
12. Schnetzler B, Drobinski G, Dorent R, Camproux AC, Ghossoub J, Thomas D, Gandjbakhch I. The role of percutaneous transluminal coronary angioplasty in heart transplant recipients. J Heart Lung Transplant 2000;19:557-565.
13. Gao SZ, Schroeder JS, Hunt S, Stinson EB. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol 1988;62:876-881.
14. Schroeder JS, Gao SZ, Alderman EL, Hunt SA, Johnstone I, Boothroyd DB, Wiederhold V, Stinson EB. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med 1993;328:164-170.
15. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995;333:621-627.
16. Weis M, Wildhirt SM, Schulze C, Pehlivanli S, Rieder G, Wolf WP, Wilbert-Lampen U, Meiser BM, Enders G, von Scheidt W. Coronary vasomotor dysfunction in the cardiac allograft: impact of different immunosuppressive regimens. J Cardiovasc Pharmacol 2000;36:776-784.
17. Suntharalingam M, Laskey W, Lansky AJ, Waksman R, White L, Teirstien P, Massullo V, Rutherford B, Elman A, Kuntz RE, Popma JJ, Bonan R. Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of instent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys 2002;52:1075-1082.
18. Waksman R, Ajani AE, White RL, Chan RC, Satler LF, Kent KM, Pichard AD, Pinnow EE, Bui AB, Ramee S, Teirstein P, Lindsay J. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med 2002;346:1194-1199.